Three IPOs priced this past week, led by the latest consumer success story, ODDITY Tech (ODD). DTC retailer ODDITY Tech priced above the raised range to raise $424 million at a $2.2 billion market cap. ODDITY’s current...read more
BioNexus Gene Lab, which distributes chemical products and provides non-invasive blood tests in Asia, raised $5 million by offering 1.3 million shares at $4. Prior to pricing, the company did not disclose a proposed range or price in its prospectus. The company...read more
Two small issuers began trading this past week, only one of which was large enough to be included in our IPO stats, as several deals postponed (SODR, MGRX) or delayed (TRNR, INTS, NRXS). Two SPACs also priced. Eight IPOs submitted initial filings, the...read more
BioNexus Gene Lab, which wholesales chemical products and provides non-invasive blood tests in Asia, filed on Tuesday with the SEC to raise up to $17 million in an initial public offering. The company is currently listed on the OTCQB under the symbol "BGLC". ...read more
US IPO Weekly Recap: ODDITY jumps 50% to become the IPO market’s latest beauty queen
Three IPOs priced this past week, led by the latest consumer success story, ODDITY Tech (ODD). DTC retailer ODDITY Tech priced above the raised range to raise $424 million at a $2.2 billion market cap. ODDITY’s current...read more
Raw material and blood test supplier BioNexus prices Nasdaq uplisting at $4
BioNexus Gene Lab, which distributes chemical products and provides non-invasive blood tests in Asia, raised $5 million by offering 1.3 million shares at $4. Prior to pricing, the company did not disclose a proposed range or price in its prospectus. The company...read more
US IPO Weekly Recap: Calendar is quieter than expected as more small IPOs join the pipeline
Two small issuers began trading this past week, only one of which was large enough to be included in our IPO stats, as several deals postponed (SODR, MGRX) or delayed (TRNR, INTS, NRXS). Two SPACs also priced. Eight IPOs submitted initial filings, the...read more
Raw material and blood test supplier BioNexus Gene Lab files for a $17 million Nasdaq uplisting
BioNexus Gene Lab, which wholesales chemical products and provides non-invasive blood tests in Asia, filed on Tuesday with the SEC to raise up to $17 million in an initial public offering. The company is currently listed on the OTCQB under the symbol "BGLC". ...read more